- Home
- KRO vs HQL Comparison
KRO vs HQL Comparison
Compare KRO & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRO | HQL |
|---|---|---|
| Founded | 1916 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 503.9M | 510.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KRO | HQL |
|---|---|---|
| Price | $4.49 | $17.21 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | ★ 299.8K | 120.9K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | 4.44% | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $1,864,200,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.29 | N/A |
| P/E Ratio | ★ N/A | $17.08 |
| Revenue Growth | ★ 0.01 | N/A |
| 52 Week Low | $4.08 | $11.34 |
| 52 Week High | $10.71 | $14.37 |
Technical Indicators
Market Signals| Indicator | KRO | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 42.54 | 54.96 |
| Support Level | $4.65 | $16.92 |
| Resistance Level | $4.96 | $17.33 |
| Average True Range (ATR) | 0.26 | 0.36 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 22.03 | 64.44 |
Price Performance
Historical ComparisonAbout KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.